APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biosimilar Insulin Lispro

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biosimilar Insulin Lispro Market Analysis and Forecast 2026-2032

Report ID 17397092022 January 2026196 pages

Choose your research edition.

Industry ResearchBiosimilar Insulin Lispro Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosimilar Insulin Lispro Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Biosimilar Insulin Lispro Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosimilar Insulin Lispro Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosimilar Insulin Lispro Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Biosimilar Insulin Lispro market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biosimilar Insulin Lispro is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biosimilar Insulin Lispro is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biosimilar Insulin Lispro is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biosimilar Insulin Lispro is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Biosimilar Insulin Lispro include Sanofi, Geropharm and Gan&Lee, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biosimilar Insulin Lispro, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biosimilar Insulin Lispro, also provides the sales of main regions and countries. Of the upcoming market potential for Biosimilar Insulin Lispro, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biosimilar Insulin Lispro sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biosimilar Insulin Lispro market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Biosimilar Insulin Lispro sales, projected growth trends, production technology, application and end-user industry.

Biosimilar Insulin Lispro Segment by Company

Sanofi

Geropharm

Gan&Lee

Biosimilar Insulin Lispro Segment by Type

Pre-filled

Cartridge

Biosimilar Insulin Lispro Segment by Application

Hospital

Retail Pharmacy

Others

Biosimilar Insulin Lispro Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimilar Insulin Lispro market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosimilar Insulin Lispro and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimilar Insulin Lispro.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Biosimilar Insulin Lispro in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Biosimilar Insulin Lispro manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilar Insulin Lispro sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biosimilar Insulin Lispro Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pre-filled Major Manufacturers Table 3. Cartridge Major Manufacturers Table 4. Global Biosimilar Insulin Lispro Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Retail Pharmacy Major Manufacturers Table 7. Others Major Manufacturers Table 8. Biosimilar Insulin Lispro Industry Trends Table 9. Biosimilar Insulin Lispro Industry Drivers Table 10. Biosimilar Insulin Lispro Industry Opportunities and Challenges Table 11. Biosimilar Insulin Lispro Industry Restraints Table 12. Global Biosimilar Insulin Lispro Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Biosimilar Insulin Lispro Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Biosimilar Insulin Lispro Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Biosimilar Insulin Lispro Revenue Market Share by Region (2021-2026) Table 16. Global Biosimilar Insulin Lispro Revenue Market Share by Region (2027-2032) Table 17. Global Biosimilar Insulin Lispro Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Biosimilar Insulin Lispro Sales by Region (2021-2026) & (K Units) Table 19. Global Biosimilar Insulin Lispro Sales by Region (2027-2032) & (K Units) Table 20. Global Biosimilar Insulin Lispro Sales Market Share by Region (2021-2026) Table 21. Global Biosimilar Insulin Lispro Sales Market Share by Region (2027-2032) Table 22. Global Biosimilar Insulin Lispro Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Biosimilar Insulin Lispro Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Biosimilar Insulin Lispro Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Biosimilar Insulin Lispro Sales Market Share by Manufacturers (2021-2026) Table 26. Global Biosimilar Insulin Lispro Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Biosimilar Insulin Lispro Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Biosimilar Insulin Lispro Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Biosimilar Insulin Lispro Manufacturers, Product Type & Application Table 30. Global Biosimilar Insulin Lispro Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Biosimilar Insulin Lispro by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Biosimilar Insulin Lispro Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biosimilar Insulin Lispro Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Biosimilar Insulin Lispro Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Biosimilar Insulin Lispro Revenue Market Share by Type (2021-2026) Table 37. Global Biosimilar Insulin Lispro Revenue Market Share by Type (2027-2032) Table 38. Global Biosimilar Insulin Lispro Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Biosimilar Insulin Lispro Sales by Type (2021-2026) & (K Units) Table 40. Global Biosimilar Insulin Lispro Sales by Type (2027-2032) & (K Units) Table 41. Global Biosimilar Insulin Lispro Sales Market Share by Type (2021-2026) Table 42. Global Biosimilar Insulin Lispro Sales Market Share by Type (2027-2032) Table 43. Global Biosimilar Insulin Lispro Price by Type (2021-2026) & (US$/Unit) Table 44. Global Biosimilar Insulin Lispro Price by Type (2027-2032) & (US$/Unit) Table 45. Global Biosimilar Insulin Lispro Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Biosimilar Insulin Lispro Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Biosimilar Insulin Lispro Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Biosimilar Insulin Lispro Revenue Market Share by Application (2021-2026) Table 49. Global Biosimilar Insulin Lispro Revenue Market Share by Application (2027-2032) Table 50. Global Biosimilar Insulin Lispro Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Biosimilar Insulin Lispro Sales by Application (2021-2026) & (K Units) Table 52. Global Biosimilar Insulin Lispro Sales by Application (2027-2032) & (K Units) Table 53. Global Biosimilar Insulin Lispro Sales Market Share by Application (2021-2026) Table 54. Global Biosimilar Insulin Lispro Sales Market Share by Application (2027-2032) Table 55. Global Biosimilar Insulin Lispro Price by Application (2021-2026) & (US$/Unit) Table 56. Global Biosimilar Insulin Lispro Price by Application (2027-2032) & (US$/Unit) Table 57. Sanofi Company Information Table 58. Sanofi Business Overview Table 59. Sanofi Biosimilar Insulin Lispro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Sanofi Biosimilar Insulin Lispro Product Portfolio Table 61. Sanofi Recent Development Table 62. Geropharm Company Information Table 63. Geropharm Business Overview Table 64. Geropharm Biosimilar Insulin Lispro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Geropharm Biosimilar Insulin Lispro Product Portfolio Table 66. Geropharm Recent Development Table 67. Gan&Lee Company Information Table 68. Gan&Lee Business Overview Table 69. Gan&Lee Biosimilar Insulin Lispro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Gan&Lee Biosimilar Insulin Lispro Product Portfolio Table 71. Gan&Lee Recent Development Table 72. North America Biosimilar Insulin Lispro Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Biosimilar Insulin Lispro Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Biosimilar Insulin Lispro Sales by Type (2021-2026) & (K Units) Table 75. North America Biosimilar Insulin Lispro Sales by Type (2027-2032) & (K Units) Table 76. North America Biosimilar Insulin Lispro Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Biosimilar Insulin Lispro Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Biosimilar Insulin Lispro Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Biosimilar Insulin Lispro Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Biosimilar Insulin Lispro Sales by Application (2021-2026) & (K Units) Table 81. North America Biosimilar Insulin Lispro Sales by Application (2027-2032) & (K Units) Table 82. North America Biosimilar Insulin Lispro Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Biosimilar Insulin Lispro Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Biosimilar Insulin Lispro Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Biosimilar Insulin Lispro Sales by Country (2021-2026) & (K Units) Table 89. North America Biosimilar Insulin Lispro Sales by Country (2027-2032) & (K Units) Table 90. North America Biosimilar Insulin Lispro Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Biosimilar Insulin Lispro Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 93. Canada Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 94. Europe Biosimilar Insulin Lispro Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Biosimilar Insulin Lispro Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Biosimilar Insulin Lispro Sales by Type (2021-2026) & (K Units) Table 97. Europe Biosimilar Insulin Lispro Sales by Type (2027-2032) & (K Units) Table 98. Europe Biosimilar Insulin Lispro Sales Price by Type (2021-2026) & (US$/Unit) Table 99. Europe Biosimilar Insulin Lispro Sales Price by Type (2027-2032) & (US$/Unit) Table 100. Europe Biosimilar Insulin Lispro Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Biosimilar Insulin Lispro Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Biosimilar Insulin Lispro Sales by Application (2021-2026) & (K Units) Table 103. Europe Biosimilar Insulin Lispro Sales by Application (2027-2032) & (K Units) Table 104. Europe Biosimilar Insulin Lispro Sales Price by Application (2021-2026) & (US$/Unit) Table 105. Europe Biosimilar Insulin Lispro Sales Price by Application (2027-2032) & (US$/Unit) Table 106. Europe Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Biosimilar Insulin Lispro Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 110. Europe Biosimilar Insulin Lispro Sales by Country (2021-2026) & (K Units) Table 111. Europe Biosimilar Insulin Lispro Sales by Country (2027-2032) & (K Units) Table 112. Europe Biosimilar Insulin Lispro Sales Price by Country (2021-2026) & (US$/Unit) Table 113. Europe Biosimilar Insulin Lispro Sales Price by Country (2027-2032) & (US$/Unit) Table 114. Germany Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 115. France Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 116. U.K. Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 117. Italy Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 118. Netherlands Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 119. China Biosimilar Insulin Lispro Revenue by Type (2021-2026) & (US$ Million) Table 120. China Biosimilar Insulin Lispro Revenue by Type (2027-2032) & (US$ Million) Table 121. China Biosimilar Insulin Lispro Sales by Type (2021-2026) & (K Units) Table 122. China Biosimilar Insulin Lispro Sales by Type (2027-2032) & (K Units) Table 123. China Biosimilar Insulin Lispro Sales Price by Type (2021-2026) & (US$/Unit) Table 124. China Biosimilar Insulin Lispro Sales Price by Type (2027-2032) & (US$/Unit) Table 125. China Biosimilar Insulin Lispro Revenue by Application (2021-2026) & (US$ Million) Table 126. China Biosimilar Insulin Lispro Revenue by Application (2027-2032) & (US$ Million) Table 127. China Biosimilar Insulin Lispro Sales by Application (2021-2026) & (K Units) Table 128. China Biosimilar Insulin Lispro Sales by Application (2027-2032) & (K Units) Table 129. China Biosimilar Insulin Lispro Sales Price by Application (2021-2026) & (US$/Unit) Table 130. China Biosimilar Insulin Lispro Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Asia Biosimilar Insulin Lispro Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Biosimilar Insulin Lispro Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Biosimilar Insulin Lispro Sales by Type (2021-2026) & (K Units) Table 134. Asia Biosimilar Insulin Lispro Sales by Type (2027-2032) & (K Units) Table 135. Asia Biosimilar Insulin Lispro Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Asia Biosimilar Insulin Lispro Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Asia Biosimilar Insulin Lispro Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Biosimilar Insulin Lispro Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Biosimilar Insulin Lispro Sales by Application (2021-2026) & (K Units) Table 140. Asia Biosimilar Insulin Lispro Sales by Application (2027-2032) & (K Units) Table 141. Asia Biosimilar Insulin Lispro Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Asia Biosimilar Insulin Lispro Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia Biosimilar Insulin Lispro Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Asia Biosimilar Insulin Lispro Sales by Country (2021-2026) & (K Units) Table 148. Asia Biosimilar Insulin Lispro Sales by Country (2027-2032) & (K Units) Table 149. Asia Biosimilar Insulin Lispro Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Asia Biosimilar Insulin Lispro Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Japan Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 152. South Korea Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 153. India Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 154. Australia Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 155. China Taiwan Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 157. SAMEA Biosimilar Insulin Lispro Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Biosimilar Insulin Lispro Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Biosimilar Insulin Lispro Sales by Type (2021-2026) & (K Units) Table 160. SAMEA Biosimilar Insulin Lispro Sales by Type (2027-2032) & (K Units) Table 161. SAMEA Biosimilar Insulin Lispro Sales Price by Type (2021-2026) & (US$/Unit) Table 162. SAMEA Biosimilar Insulin Lispro Sales Price by Type (2027-2032) & (US$/Unit) Table 163. SAMEA Biosimilar Insulin Lispro Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Biosimilar Insulin Lispro Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Biosimilar Insulin Lispro Sales by Application (2021-2026) & (K Units) Table 166. SAMEA Biosimilar Insulin Lispro Sales by Application (2027-2032) & (K Units) Table 167. SAMEA Biosimilar Insulin Lispro Sales Price by Application (2021-2026) & (US$/Unit) Table 168. SAMEA Biosimilar Insulin Lispro Sales Price by Application (2027-2032) & (US$/Unit) Table 169. SAMEA Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA Biosimilar Insulin Lispro Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. SAMEA Biosimilar Insulin Lispro Sales by Country (2021-2026) & (K Units) Table 174. SAMEA Biosimilar Insulin Lispro Sales by Country (2027-2032) & (K Units) Table 175. SAMEA Biosimilar Insulin Lispro Sales Price by Country (2021-2026) & (US$/Unit) Table 176. SAMEA Biosimilar Insulin Lispro Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Brazil Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 178. Argentina Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 179. Chile Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 180. Colombia Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 181. Peru Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 183. Israel Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 184. UAE Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 185. Turkey Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 186. Iran Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 187. Egypt Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Biosimilar Insulin Lispro Distributors List Table 191. Biosimilar Insulin Lispro Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Biosimilar Insulin Lispro Image Figure 2. Global Biosimilar Insulin Lispro Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biosimilar Insulin Lispro Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pre-filled Image Figure 5. Cartridge Image Figure 6. Global Biosimilar Insulin Lispro Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biosimilar Insulin Lispro Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Retail Pharmacy Image Figure 10. Others Image Figure 11. Global Biosimilar Insulin Lispro Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Biosimilar Insulin Lispro Revenue (2021-2032) & (US$ Million) Figure 13. Global Biosimilar Insulin Lispro Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Biosimilar Insulin Lispro Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Biosimilar Insulin Lispro Revenue Market Share by Region (2021-2032) Figure 16. Global Biosimilar Insulin Lispro Sales (2021-2032) & (K Units) Figure 17. Global Biosimilar Insulin Lispro Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Biosimilar Insulin Lispro Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Biosimilar Insulin Lispro Sales YoY (2021-2032) & (K Units) Figure 20. Europe Biosimilar Insulin Lispro Sales YoY (2021-2032) & (K Units) Figure 21. China Biosimilar Insulin Lispro Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Biosimilar Insulin Lispro Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Biosimilar Insulin Lispro Sales YoY (2021-2032) & (K Units) Figure 24. Global Biosimilar Insulin Lispro Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Biosimilar Insulin Lispro Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Biosimilar Insulin Lispro Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Biosimilar Insulin Lispro Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Biosimilar Insulin Lispro Revenue Market Share by Type (2021-2032) Figure 30. Global Biosimilar Insulin Lispro Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Biosimilar Insulin Lispro Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Biosimilar Insulin Lispro Sales Market Share by Type (2021-2032) Figure 33. Global Biosimilar Insulin Lispro Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Biosimilar Insulin Lispro Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Biosimilar Insulin Lispro Revenue Market Share by Application (2021-2032) Figure 36. Global Biosimilar Insulin Lispro Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Biosimilar Insulin Lispro Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Biosimilar Insulin Lispro Sales Market Share by Application (2021-2032) Figure 39. North America Biosimilar Insulin Lispro Revenue Share by Type (2021-2032) Figure 40. North America Biosimilar Insulin Lispro Sales Share by Type (2021-2032) Figure 41. North America Biosimilar Insulin Lispro Revenue Share by Application (2021-2032) Figure 42. North America Biosimilar Insulin Lispro Sales Share by Application (2021-2032) Figure 43. North America Biosimilar Insulin Lispro Revenue Share by Country (2021-2032) Figure 44. North America Biosimilar Insulin Lispro Sales Share by Country (2021-2032) Figure 45. Europe Biosimilar Insulin Lispro Revenue Share by Type (2021-2032) Figure 46. Europe Biosimilar Insulin Lispro Sales Share by Type (2021-2032) Figure 47. Europe Biosimilar Insulin Lispro Revenue Share by Application (2021-2032) Figure 48. Europe Biosimilar Insulin Lispro Sales Share by Application (2021-2032) Figure 49. Europe Biosimilar Insulin Lispro Revenue Share by Country (2021-2032) Figure 50. Europe Biosimilar Insulin Lispro Sales Share by Country (2021-2032) Figure 51. China Biosimilar Insulin Lispro Revenue Share by Type (2021-2032) Figure 52. China Biosimilar Insulin Lispro Sales Share by Type (2021-2032) Figure 53. China Biosimilar Insulin Lispro Revenue Share by Application (2021-2032) Figure 54. China Biosimilar Insulin Lispro Sales Share by Application (2021-2032) Figure 55. Asia Biosimilar Insulin Lispro Revenue Share by Type (2021-2032) Figure 56. Asia Biosimilar Insulin Lispro Sales Share by Type (2021-2032) Figure 57. Asia Biosimilar Insulin Lispro Revenue Share by Application (2021-2032) Figure 58. Asia Biosimilar Insulin Lispro Sales Share by Application (2021-2032) Figure 59. Asia Biosimilar Insulin Lispro Revenue Share by Country (2021-2032) Figure 60. Asia Biosimilar Insulin Lispro Sales Share by Country (2021-2032) Figure 61. SAMEA Biosimilar Insulin Lispro Revenue Share by Type (2021-2032) Figure 62. SAMEA Biosimilar Insulin Lispro Sales Share by Type (2021-2032) Figure 63. SAMEA Biosimilar Insulin Lispro Revenue Share by Application (2021-2032) Figure 64. SAMEA Biosimilar Insulin Lispro Sales Share by Application (2021-2032) Figure 65. SAMEA Biosimilar Insulin Lispro Revenue Share by Country (2021-2032) Figure 66. SAMEA Biosimilar Insulin Lispro Sales Share by Country (2021-2032) Figure 67. Biosimilar Insulin Lispro Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Biosimilar Insulin Lispro Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Pre-filled
  • Cartridge
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Sanofi
  • Geropharm
  • Gan&Lee

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biosimilar Insulin Lispro Market by Type
  3. 1.2.1 Global Biosimilar Insulin Lispro Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pre-filled
  5. 1.2.3 Cartridge
  6. 1.3 Biosimilar Insulin Lispro Market by Application
  7. 1.3.1 Global Biosimilar Insulin Lispro Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Retail Pharmacy
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Biosimilar Insulin Lispro Market Dynamics
  1. 2.1 Biosimilar Insulin Lispro Industry Trends
  2. 2.2 Biosimilar Insulin Lispro Industry Drivers
  3. 2.3 Biosimilar Insulin Lispro Industry Opportunities and Challenges
  4. 2.4 Biosimilar Insulin Lispro Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Biosimilar Insulin Lispro Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Biosimilar Insulin Lispro Revenue by Region
  3. 3.2.1 Global Biosimilar Insulin Lispro Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biosimilar Insulin Lispro Revenue by Region (2021-2026)
  5. 3.2.3 Global Biosimilar Insulin Lispro Revenue by Region (2027-2032)
  6. 3.2.4 Global Biosimilar Insulin Lispro Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Biosimilar Insulin Lispro Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Biosimilar Insulin Lispro Sales by Region
  9. 3.4.1 Global Biosimilar Insulin Lispro Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Biosimilar Insulin Lispro Sales by Region (2021-2026)
  11. 3.4.3 Global Biosimilar Insulin Lispro Sales by Region (2027-2032)
  12. 3.4.4 Global Biosimilar Insulin Lispro Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Biosimilar Insulin Lispro Revenue by Manufacturers
  2. 4.1.1 Global Biosimilar Insulin Lispro Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Biosimilar Insulin Lispro Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Biosimilar Insulin Lispro Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biosimilar Insulin Lispro Sales by Manufacturers
  6. 4.2.1 Global Biosimilar Insulin Lispro Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Biosimilar Insulin Lispro Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Biosimilar Insulin Lispro Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Biosimilar Insulin Lispro Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Biosimilar Insulin Lispro Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Biosimilar Insulin Lispro Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Biosimilar Insulin Lispro Manufacturers, Product Type & Application
  13. 4.7 Global Biosimilar Insulin Lispro Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Biosimilar Insulin Lispro Market CR5 and HHI
  16. 4.8.2 2025 Biosimilar Insulin Lispro Tier 1, Tier 2, and Tier 3
5 Biosimilar Insulin Lispro Market by Type
  1. 5.1 Global Biosimilar Insulin Lispro Revenue by Type
  2. 5.1.1 Global Biosimilar Insulin Lispro Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Biosimilar Insulin Lispro Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Biosimilar Insulin Lispro Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Biosimilar Insulin Lispro Sales by Type
  6. 5.2.1 Global Biosimilar Insulin Lispro Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biosimilar Insulin Lispro Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Biosimilar Insulin Lispro Sales Market Share by Type (2021-2032)
  9. 5.3 Global Biosimilar Insulin Lispro Price by Type
6 Biosimilar Insulin Lispro Market by Application
  1. 6.1 Global Biosimilar Insulin Lispro Revenue by Application
  2. 6.1.1 Global Biosimilar Insulin Lispro Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Biosimilar Insulin Lispro Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Biosimilar Insulin Lispro Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Biosimilar Insulin Lispro Sales by Application
  6. 6.2.1 Global Biosimilar Insulin Lispro Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Biosimilar Insulin Lispro Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Biosimilar Insulin Lispro Sales Market Share by Application (2021-2032)
  9. 6.3 Global Biosimilar Insulin Lispro Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Biosimilar Insulin Lispro Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Biosimilar Insulin Lispro Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Geropharm
  8. 7.2.1 Geropharm Company Information
  9. 7.2.2 Geropharm Business Overview
  10. 7.2.3 Geropharm Biosimilar Insulin Lispro Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Geropharm Biosimilar Insulin Lispro Product Portfolio
  12. 7.2.5 Geropharm Recent Developments
  13. 7.3 Gan&Lee
  14. 7.3.1 Gan&Lee Company Information
  15. 7.3.2 Gan&Lee Business Overview
  16. 7.3.3 Gan&Lee Biosimilar Insulin Lispro Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gan&Lee Biosimilar Insulin Lispro Product Portfolio
  18. 7.3.5 Gan&Lee Recent Developments
8 North America
  1. 8.1 North America Biosimilar Insulin Lispro Market Size by Type
  2. 8.1.1 North America Biosimilar Insulin Lispro Revenue by Type (2021-2032)
  3. 8.1.2 North America Biosimilar Insulin Lispro Sales by Type (2021-2032)
  4. 8.1.3 North America Biosimilar Insulin Lispro Price by Type (2021-2032)
  5. 8.2 North America Biosimilar Insulin Lispro Market Size by Application
  6. 8.2.1 North America Biosimilar Insulin Lispro Revenue by Application (2021-2032)
  7. 8.2.2 North America Biosimilar Insulin Lispro Sales by Application (2021-2032)
  8. 8.2.3 North America Biosimilar Insulin Lispro Price by Application (2021-2032)
  9. 8.3 North America Biosimilar Insulin Lispro Market Size by Country
  10. 8.3.1 North America Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Biosimilar Insulin Lispro Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Biosimilar Insulin Lispro Market Size by Type
  2. 9.1.1 Europe Biosimilar Insulin Lispro Revenue by Type (2021-2032)
  3. 9.1.2 Europe Biosimilar Insulin Lispro Sales by Type (2021-2032)
  4. 9.1.3 Europe Biosimilar Insulin Lispro Price by Type (2021-2032)
  5. 9.2 Europe Biosimilar Insulin Lispro Market Size by Application
  6. 9.2.1 Europe Biosimilar Insulin Lispro Revenue by Application (2021-2032)
  7. 9.2.2 Europe Biosimilar Insulin Lispro Sales by Application (2021-2032)
  8. 9.2.3 Europe Biosimilar Insulin Lispro Price by Application (2021-2032)
  9. 9.3 Europe Biosimilar Insulin Lispro Market Size by Country
  10. 9.3.1 Europe Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Biosimilar Insulin Lispro Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Biosimilar Insulin Lispro Market Size by Type
  2. 10.1.1 China Biosimilar Insulin Lispro Revenue by Type (2021-2032)
  3. 10.1.2 China Biosimilar Insulin Lispro Sales by Type (2021-2032)
  4. 10.1.3 China Biosimilar Insulin Lispro Price by Type (2021-2032)
  5. 10.2 China Biosimilar Insulin Lispro Market Size by Application
  6. 10.2.1 China Biosimilar Insulin Lispro Revenue by Application (2021-2032)
  7. 10.2.2 China Biosimilar Insulin Lispro Sales by Application (2021-2032)
  8. 10.2.3 China Biosimilar Insulin Lispro Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biosimilar Insulin Lispro Market Size by Type
  2. 11.1.1 Asia Biosimilar Insulin Lispro Revenue by Type (2021-2032)
  3. 11.1.2 Asia Biosimilar Insulin Lispro Sales by Type (2021-2032)
  4. 11.1.3 Asia Biosimilar Insulin Lispro Price by Type (2021-2032)
  5. 11.2 Asia Biosimilar Insulin Lispro Market Size by Application
  6. 11.2.1 Asia Biosimilar Insulin Lispro Revenue by Application (2021-2032)
  7. 11.2.2 Asia Biosimilar Insulin Lispro Sales by Application (2021-2032)
  8. 11.2.3 Asia Biosimilar Insulin Lispro Price by Application (2021-2032)
  9. 11.3 Asia Biosimilar Insulin Lispro Market Size by Country
  10. 11.3.1 Asia Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Biosimilar Insulin Lispro Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biosimilar Insulin Lispro Market Size by Type
  2. 12.1.1 SAMEA Biosimilar Insulin Lispro Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Biosimilar Insulin Lispro Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Biosimilar Insulin Lispro Price by Type (2021-2032)
  5. 12.2 SAMEA Biosimilar Insulin Lispro Market Size by Application
  6. 12.2.1 SAMEA Biosimilar Insulin Lispro Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Biosimilar Insulin Lispro Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Biosimilar Insulin Lispro Price by Application (2021-2032)
  9. 12.3 SAMEA Biosimilar Insulin Lispro Market Size by Country
  10. 12.3.1 SAMEA Biosimilar Insulin Lispro Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Biosimilar Insulin Lispro Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Biosimilar Insulin Lispro Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Biosimilar Insulin Lispro Value Chain Analysis
  2. 13.1.1 Biosimilar Insulin Lispro Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Biosimilar Insulin Lispro Production Mode & Process
  6. 13.2 Biosimilar Insulin Lispro Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Biosimilar Insulin Lispro Distributors
  9. 13.2.3 Biosimilar Insulin Lispro Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst